Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
S-Adenosylmethionine Decarboxylase (AdoMetDC) is a critical enzyme in polyamine biosynthesis that catalyzes the conversion of S-adenosyl methionine to S-adenosylmethioninamine (decarboxylated S-adenosylmethionine). It is essential for cellular growth and function, and its activity is tightly regulated. AdoMetDC utilizes a covalently bound pyruvate residue as its essential prosthetic group for the decarboxylation reaction. Inhibitors of AdoMetDC have potential applications as anticancer and anti-trypanosomal agents.
Inhibition of S-Adenosylmethionine Decarboxylase, thereby reducing polyamine synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on S-Adenosylmethionine Decarboxylase (AdoMetDC).